Dr. Clarke is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
20 Duke Medicine Cir
Durham, NC 27710Phone+1 919-668-6688- Is this information wrong?
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 2011 - 2014- Duke University HospitalResidency, Internal Medicine, 2008 - 2011
Indiana University School of MedicineClass of 2008
Certifications & Licensure
NC State Medical License 2008 - 2025
Clinical Trials
- Phase Ib First in Human Dose Escalation of GT103 in Refractory, Advanced Stage Non-Small Cell Lung Cancer (TOP 1902) Start of enrollment: 2020 Jun 09
Publications & Presentations
PubMed
- Long-Term Intracranial Outcomes With Combination Dual Immune-Checkpoint Blockade and Stereotactic Radiosurgery in Patients With Melanoma and Non-Small Cell Lung Cancer...Eugene J Vaios, Rachel F Shenker, Peter G Hendrickson, Zihan Wan, Donna Niedzwiecki, Sebastian F Winter, Helen A Shih, Jorg Dietrich, Chunhao Wang, April K S Salama, J...> ;International Journal of Radiation Oncology, Biology, Physics. 2024 Apr 1
- A plain language summary of the PHAROS study: the combination of encorafenib and binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer.Riely, G., Smit, E., Ahn, M., Felip, E., Ramalingam, S., Tsao, A., Johnson, M., Gelsomino, F., Esper, R., Nadal, E., Offin, M., Provencio, M., Clarke, J., Hussein, M.,...> ;Future Oncology. 2024 Feb 15
- 6 citationsPhase II, Open-Label Study of Encorafenib Plus Binimetinib in Patients With-Mutant Metastatic Non-Small-Cell Lung Cancer.Gregory J Riely, Egbert F Smit, Myung-Ju Ahn, Enriqueta Felip, Suresh S Ramalingam, Anne Tsao, Melissa Johnson, Francesco Gelsomino, Raymond Esper, Ernest Nadal, Micha...> ;Journal of Clinical Oncology. 2023 Jul 20
- Join now to see all
Lectures
- Real-world tumor response (rwTR) to ramucirumab plus docetaxel (R+D) post platinum-based (Pt) and immune checkpoint inhibitor (ICI) therapy in advanced non-small cell ...2019 ASCO Annual Meeting - 6/1/2019
- Real-world (rw) clinical outcomes for advanced/metastatic non-small cell lung cancer (aNSCLC) patients (pts) treated with second line (2L) ramucirumab plus docetaxel (...2019 ASCO Annual Meeting - 6/1/2019
- Veliparib in combination with nivolumab and platinum doublet chemotherapy (CT) in metastatic/advanced NSCLC.2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
Press Mentions
Poziotinib Shows Promise in Hard-to-Treat NSCLC Exon 20 MutationsNovember 7th, 2019
Spectrum Announces Expansion of the Poziotinib Clinical ProgramJuly 22nd, 2019- OncLive® Presents State of the Science Summit™ on Non-Small Cell Lung CancerMay 8th, 2019
Hospital Affiliations
Duke University HospitalDurham, North Carolina
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
